Poster

Rebecca Baillie, Chris Schelling, Richard Ridgewell, Tongli Zhang, Christina Friedrich, Mike Reed

Reuse of a published model with fasting data from a novel drug formulation for a rare disorder

Presented by Acer Therapeutics and Rosa at the Population Approach Group in Europe (PAGE) meeting, September 2021

Poster

Vincent Hurez, Krishnakant Dasika, Katherine Kudrycki, Robert Sheehan, Christina Friedrich, Mike Reed, Glenn Gauderat, Audrey Aussy, Loubna Chadli, Florian Chassereau, Sylvain Fouliard, Sandra Hubert, Emiko Desvaux, Perrine Soret, Alexia Blesius, Philippe Moingeon

Development of a systemic lupus erythematosus (SLE) QSP model linking systemic biomarkers to cutaneous clinical score (CLASI) outcomes.

Presented by Servier and Rosa at the Population Approach Group in Europe (PAGE) meeting, September 2021

Abstract

Rebecca Baillie, Chris Schelling, Richard Ridgewell, Tongli Zhang, Christina Friedrich, Mike Reed

Reuse of a published model to support compassionate use of novel drug formulation for a rare disorder

Presented by Acer Therapeutics and Rosa at the American Society of Clinical Oncology (ASCO), June 2021

Peer Reviewed Journal Publication

Jane P. F. Bai, Brian J. Schmidt, Kapil G. Gadkar, Valeriu Damian, Justin C. Earp, Christina Friedrich, Piet H. van der Graaf, Rajanikanth Madabushi, Cynthia J. Musante, Kunal Naik, Mark Rogge, Hao Zhu

FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective

Published in AAPS Journal, Apr. 30, 2021

"We enable our clients to learn things that would be impractical or impossible to learn from empirical studies alone."
—Mike Reed, PhD, Chief Scientist, PhysioPD
Learn more about PhysioPD